Last reviewed · How we verify
NCT04630704
Evaluating A Non-Invasive Tissue Perfusion Monitor
trial testing Pedra in Circulatory; Change in 50 participants. Status unknown.
1 April 2021
Quick facts
| Lead sponsor | Pedra Technology, PTE LTD |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 7 December 2020 |
| Primary completion | 1 April 2021 |
| Estimated completion | 1 July 2021 |
Drugs / interventions tested
- Pedra
Conditions studied
- Circulatory; Change — all drugs for Circulatory; Change →
Sponsor
Pedra Technology, PTE LTD
Who can join
Adults 40 to 90, any sex, with Circulatory; Change. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Pedra perfusion system will be used to assess changes in perfusion in response to physiological stimuli. It will be compared to other standard diagnostics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04630704
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Pedra Technology, PTE LTD trials
Trials by the same sponsor.
- NCT04956523 — Preliminary Tissue Monitoring During Endovascular Intervention Study · unknown
- NCT04744870 — Tissue Monitoring During Endovascular Intervention · unknown
- NCT03294902 — Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04630704 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pedra Technology, PTE LTD
- Last refreshed: 16 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04630704.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing